Cooper Companies (COO) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Cooper Companies (COO) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -6.52% |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 10.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 10.63% |
| Jan 31, 2026 | 14.32% |
| Oct 31, 2025 | -30.00% |
| Jul 31, 2025 | 8.88% |
| Apr 30, 2025 | 5.40% |
| Jan 31, 2025 | -24.30% |
| Oct 31, 2024 | -3.45% |
| Jul 31, 2024 | -2.09% |
| Apr 30, 2024 | 0.68% |
| Jan 31, 2024 | 42.29% |
| Oct 31, 2023 | 52.79% |
| Jul 31, 2023 | 95.06% |
| Apr 30, 2023 | 69.59% |
| Jan 31, 2023 | 45.36% |
| Oct 31, 2022 | 46.00% |
| Jul 31, 2022 | 6.88% |
| Apr 30, 2022 | -13.03% |
| Jan 31, 2022 | 2.15% |
| Oct 31, 2021 | -39.25% |
| Jul 31, 2021 | -3.33% |